{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:29:04Z","timestamp":1785230944363,"version":"3.55.0"},"reference-count":40,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objective: Radiotherapy for leukemia, the most common childhood malignancy, often exposes patients to radiation, increasing the risk of second malignancies, including thyroid cancer. To assess the incidence and survival outcomes of thyroid cancer after childhood acute lymphoblastic leukemia (ALL). Methods: We systematically reviewed articles reporting the incidence of thyroid cancer in childhood leukemia survivors (age at diagnosis &lt; 18 years) published between 2000\u20132024 in Science Direct, PubMed, Google Scholar, CENTRAL, and EMBASE. The Newcastle Ottawa Scale was utilized to appraise the methodological quality of the included studies. Descriptive statistics and calculations of incidence were performed using Microsoft Excel. Results: The literature search yielded 1265 articles, of which 18 met the inclusion criteria. Data from 135,861 childhood cancer survivors, among whom 102,070 had a confirmed diagnosis of childhood leukemia, including ALL. The crude incidence of secondary malignancies after childhood leukemia was 10.1 per 1000 patients. Among these, 1.5 per 1000 patients developed second thyroid carcinomas. Overall, 14.6% of the second malignancies in childhood leukemia survivors were thyroid carcinomas, mostly of the papillary type. Survival rates after second thyroid cancer were 100% in all 11\/18 studies reporting this outcome. Radiotherapy had been used as part of ALL treatments in 17\/18 studies. The use of radiotherapy, female sex, and younger age at the diagnosis of primary ALL emerged as important risk factors for thyroid cancer. Conclusions: Thyroid carcinomas account for ~15% of secondary malignancies after childhood leukemia, with radiation remaining a significant risk factor despite its overall reduced use for the treatment of ALL in the last few decades. Importantly, survival rates remain high. Further research is warranted to determine the incidence and outcomes of thyroid cancer in childhood ALL survivors<\/jats:p>","DOI":"10.3390\/jcm14124248","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:40:27Z","timestamp":1750056027000},"page":"4248","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thyroid Cancer in Childhood Leukemia Survivors: A Systematic Review of the Incidence and Survival Outcomes"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2531-2313","authenticated-orcid":false,"given":"Vasiliki Rengina","family":"Tsinopoulou","sequence":"first","affiliation":[{"name":"2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-4471","authenticated-orcid":false,"given":"Eleni P.","family":"Kotanidou","sequence":"additional","affiliation":[{"name":"2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-9196","authenticated-orcid":false,"given":"Savvas","family":"Kolanis","sequence":"additional","affiliation":[{"name":"2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4294-2605","authenticated-orcid":false,"given":"Athanasios","family":"Tragiannidis","sequence":"additional","affiliation":[{"name":"2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7535-2970","authenticated-orcid":false,"given":"Emmanouel","family":"Hatzipantelis","sequence":"additional","affiliation":[{"name":"2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8503-3893","authenticated-orcid":false,"given":"Assimina","family":"Galli-Tsinopoulou","sequence":"additional","affiliation":[{"name":"2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/10408360601147536","article-title":"The Epidemiology of Childhood Leukemia with a Focus on Birth Weight and Diet","volume":"44","author":"Tower","year":"2007","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Marcotte, E.L., Spector, L.G., Mendes-De-Almeida, D.P., and Nelson, H.H. (2021). The prenatal origin of childhood leukemia: Potential applications for epidemiology and newborn screening. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.639479"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.canep.2012.12.011","article-title":"The Childhood Leukemia International Consortium","volume":"37","author":"Metayer","year":"2013","journal-title":"Cancer Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrc1164","article-title":"Origins of Chromosome Translocations in Childhood Leukaemia","volume":"3","author":"Greaves","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2023.16875","article-title":"Clinical Care for People Who Survive Childhood Cancer: A Review","volume":"330","author":"Bhatia","year":"2023","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/jnci\/djq238","article-title":"Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study","volume":"102","author":"Friedman","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20180390","DOI":"10.1259\/bjr.20180390","article-title":"Review of Risk Factors of Secondary Cancers among Cancer Survivors","volume":"92","year":"2019","journal-title":"Br. J. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/jrr\/rrad073","article-title":"Thyroid Cancer Risk after Radiation Exposure in Adults-Systematic Review and Meta-Analysis","volume":"64","author":"Mirkatouli","year":"2023","journal-title":"J. Radiat. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Jairam, V., Roberts, K.B., and Yu, J.B. (2012). Historical Trends in the Use of Radiation for Pediatric Cancers: 1973\u20132008. Int. J. Radiat. Oncol. Biol. Phys., 85.","DOI":"10.1016\/j.ijrobp.2012.10.007"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_11","unstructured":"Landman, A.J.E.M.C., Don, E.E., Vissers, G., Ket, H.C.J., Oudijk, M.A., de Groot, C.J.M., Huirne, J.A.F., and de Boer, M.A. (2022). Modified Newcastle Ottawa Quality Assessment Scale and AHRQ Standards. PLoS ONE."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/cncr.11362","article-title":"Thyroid Neoplasms after Therapeutic Radiation for Malignancies during Childhood or Adolescence","volume":"97","author":"Acharya","year":"2003","journal-title":"Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.33145\/2304-8336-2021-26-309-318","article-title":"Thyroid disease in the late observation period upon chemo and radiotherapy in children\/survivors of acute lymphoblastic leukemia","volume":"26","author":"Bebeshko","year":"2021","journal-title":"Probl. Radiac. Med. Radiobiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/08880018.2011.562601","article-title":"Second Malignant Neoplasms Following Childhood Cancer: A Study of a Recent Cohort (1987\u20132004) from the Childhood Cancer Registry of the Rh\u00f4ne-Alpes Region (ARCERRA) in France","volume":"28","author":"Berger","year":"2011","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1182\/blood.V99.12.4257","article-title":"Low Incidence of Second Neoplasms among Children Diagnosed with Acute Lymphoblastic Leukemia after 1983","volume":"99","author":"Bhatia","year":"2002","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejca.2007.09.019","article-title":"Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood","volume":"44","author":"Borgmann","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anpedi.2024.01.008","article-title":"The Paradigm of Total Body Irradiation in Acute Lymphoblastic Leukaemia: Therapeutic Effectiveness versus the Challenges of Toxicity","volume":"100","author":"Echecopar","year":"2024","journal-title":"An. Pediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S0022-3468(03)00563-3","article-title":"Thyroid Carcinoma Presenting in Childhood or after Treatment of Childhood Malignancies: An Institutional Experience and Review of the Literature","volume":"38","author":"Gow","year":"2003","journal-title":"J. Pediatr. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3346\/jkms.2016.31.8.1254","article-title":"Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey","volume":"31","author":"Koh","year":"2016","journal-title":"J. Korean Med. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Martucci, C., Crocoli, A., De Pasquale, M.D., Spinelli, C., Strambi, S., Brazzarola, P., Morelli, E., Cassiani, J., Mancera, J., and Luengas, J.P. (2022). Thyroid Cancer in Children: A Multicenter International Study Highlighting Clinical Features and Surgical Outcomes of Primary and Secondary Tumors. Front. Pediatr., 10.","DOI":"10.3389\/fped.2022.914942"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jnci\/djk180","article-title":"Risk of Second Malignant Neoplasms after Childhood Leukemia and Lymphoma: An International Study","volume":"99","author":"Maule","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3324\/haematol.2015.140053","article-title":"Late Thyroid Complications in Survivors of Childhood Acute Leukemia. An L.E.A. Study","volume":"101","author":"Oudin","year":"2016","journal-title":"Haematologica"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11764-013-0292-8","article-title":"Risk of Subsequent Malignancies in Survivors of Childhood Leukemia","volume":"7","author":"Perkins","year":"2013","journal-title":"J. Cancer Surviv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pbc.23083","article-title":"Second Neoplasm in Children Treated in EORTC 58881 Trial for Acute Lymphoblastic Malignancies: Low Incidence of CNS Tumours","volume":"57","author":"Renard","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1200\/JCO.2012.47.0500","article-title":"Second Malignant Neoplasms after Treatment of Childhood Acute Lymphoblastic Leukemia","volume":"31","author":"Schiemegelow","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1200\/JCO.2000.18.2.348","article-title":"New Malignant Diseases after Allogeneic Marrow Transplantation for Childhood Acute Leukemia","volume":"18","author":"Curtis","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/ijc.24581","article-title":"Risk of Thyroid Cancer in Survivors of Childhood Cancer: Results from the British Childhood Cancer Survivor Study","volume":"125","author":"Taylor","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1097\/MPH.0000000000002881","article-title":"Prognosis of Second Primary Malignancies in Pediatric Acute Lymphoblastic Leukemia Survivors: A Multicenter Study by the Turkish Pediatric Hematology Society","volume":"46","author":"Toret","year":"2024","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/1055-9965.EPI-11-0576","article-title":"Chemotherapy and Thyroid Cancer Risk: A Report from the Childhood Cancer Survivor Study","volume":"21","author":"Veiga","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.beem.2008.09.020","article-title":"Twenty Years\u2019 Experience with Post-Chernobyl Thyroid Cancer","volume":"22","author":"Williams","year":"2008","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/cncr.29044","article-title":"The RET Oncogene in Papillary Thyroid Carcinoma","volume":"121","author":"Prescott","year":"2015","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10654-018-0467-8","article-title":"Radiotherapy for Childhood Cancer and Subsequent Thyroid Cancer Risk: A Systematic Review","volume":"33","author":"Lorenz","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e2021053127","DOI":"10.1542\/peds.2021-053127","article-title":"Long-Term Follow-up Care for Childhood, Adolescent, and Young Adult Cancer Survivors","volume":"148","author":"Hudson","year":"2021","journal-title":"Pediatrics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11764-016-0588-6","article-title":"Screening for Thyroid Cancer in Survivors of Childhood and Young Adult Cancer Treated with Neck Radiation","volume":"11","author":"Tonorezos","year":"2016","journal-title":"J. Cancer Surviv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/endrev\/bnab040","article-title":"Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors","volume":"43","author":"Mulder","year":"2022","journal-title":"Endocr. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1089\/thy.2017.0159","article-title":"Diagnostic X-Ray Exposure and Thyroid Cancer Risk: Systematic Review and Meta-Analysis","volume":"28","author":"Han","year":"2018","journal-title":"Thyroid"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1210\/er.2010-0003","article-title":"Exposing the Thyroid to Radiation: A Review of Its Current Extent, Risks, and Implications","volume":"31","author":"Sinnott","year":"2010","journal-title":"Endocr. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1667\/RR2889.1","article-title":"A Pooled Analysis of Thyroid Cancer Incidence Following Radiotherapy for Childhood Cancer","volume":"178","author":"Veiga","year":"2012","journal-title":"Radiat. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up\u2020","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_40","unstructured":"American Cancer Society (2025, March 07). Thyroid Cancer Survival Rates, by Type and Stage. Available online: https:\/\/www.cancer.org\/cancer\/types\/thyroid-cancer\/detection-diagnosis-staging\/survival-rates.html."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4248\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:52:12Z","timestamp":1760032332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14124248"],"URL":"https:\/\/doi.org\/10.3390\/jcm14124248","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]}}}